Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
- PMID: 38871006
- PMCID: PMC11485229
- DOI: 10.1038/s41591-024-03130-3
Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
Abstract
Outbreaks of monkeypox (mpox) have historically resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MPXV in West Africa. In 2022, subclade IIb caused a global epidemic linked to transmission through sexual contact. Here we describe the epidemiological and genomic features of an mpox outbreak in a mining region in eastern Democratic Republic of the Congo, caused by clade I MPXV. Surveillance data collected between September 2023 and January 2024 identified 241 suspected cases. Genomic analysis demonstrates a distinct clade I lineage divergent from previously circulating strains in the Democratic Republic of the Congo. Of the 108 polymerase chain reaction-confirmed mpox cases, the median age of individuals was 22 years, 51.9% were female and 29% were sex workers, suggesting a potential role for sexual transmission. The predominance of APOBEC3-type mutations and the estimated emergence time around mid-September 2023 imply recent sustained human-to-human transmission.
© 2024. The Author(s).
Conflict of interest statement
None of the authors declare competing interests.
Figures


Similar articles
-
Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission.Cell. 2025 Jan 9;188(1):4-14.e6. doi: 10.1016/j.cell.2024.10.017. Epub 2024 Oct 24. Cell. 2025. PMID: 39454573
-
Clade Ia Monkeypox Virus Linked to Sexual Transmission, Democratic Republic of the Congo, August 2024.Emerg Infect Dis. 2025 May;31(5):1033-1037. doi: 10.3201/eid3105.241690. Epub 2025 Apr 22. Emerg Infect Dis. 2025. PMID: 40263113 Free PMC article.
-
Complete Genome Sequencing, Annotation, and Mutational Profiling of the Novel Clade I Human Mpox Virus, Kamituga Strain.J Infect Dev Ctries. 2024 Apr 30;18(4):600-608. doi: 10.3855/jidc.20136. J Infect Dev Ctries. 2024. PMID: 38728644
-
Monkeypox Virus: WHO's Second Public Health Emergency of International Concern Within 2 Years.Microb Biotechnol. 2025 Apr;18(4):e70142. doi: 10.1111/1751-7915.70142. Microb Biotechnol. 2025. PMID: 40193168 Free PMC article. Review.
-
Exploring the genomic basis of Mpox virus-host transmission and pathogenesis.mSphere. 2024 Dec 19;9(12):e0057624. doi: 10.1128/msphere.00576-24. Epub 2024 Nov 14. mSphere. 2024. PMID: 39540739 Free PMC article. Review.
Cited by
-
Mpox in Central Africa: complex epidemiology requires a constellation approach.Npj Viruses. 2024 Dec 30;2(1):69. doi: 10.1038/s44298-024-00081-x. Npj Viruses. 2024. PMID: 40295713 Free PMC article.
-
Genomic Evolution and Epidemiological Impact of Ongoing Clade Ib MPox Disease: A Narrative Review.Glob Health Epidemiol Genom. 2025 May 15;2025:8845911. doi: 10.1155/ghe3/8845911. eCollection 2025. Glob Health Epidemiol Genom. 2025. PMID: 40406501 Free PMC article. Review.
-
Ocular Manifestations of Mpox and Other Poxvirus Infections: Clinical Insights and Emerging Therapeutic and Preventive Strategies.Vaccines (Basel). 2025 May 21;13(5):546. doi: 10.3390/vaccines13050546. Vaccines (Basel). 2025. PMID: 40432155 Free PMC article. Review.
-
Epidemiological and genomic evolution of the ongoing outbreak of clade Ib mpox virus in the eastern Democratic Republic of the Congo.Nat Med. 2025 May;31(5):1459-1463. doi: 10.1038/s41591-025-03582-1. Epub 2025 Feb 11. Nat Med. 2025. PMID: 39933565 Free PMC article.
-
Clade Ib Mpox Outbreak - Kenya, July 2024-February 2025.MMWR Morb Mortal Wkly Rep. 2025 Jun 19;74(22):379-384. doi: 10.15585/mmwr.mm7422a2. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40531681 Free PMC article.
References
-
- Van Dijck, C. et al. Emergence of mpox in the post-smallpox era—a narrative review on mpox epidemiology. Clin. Microbiol Infect.29, 1487–1492 (2023). - PubMed
-
- 2022–24 mpox (monkeypox) outbreak: global trends. World Health Organization (2024); https://worldhealthorg.shinyapps.io/mpx_global/
MeSH terms
Grants and funding
- U01 AI096299/AI/NIAID NIH HHS/United States
- 5U01AI096299-13/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R21 TW011706/TW/FIC NIH HHS/United States
- R25TW011217/U.S. Department of Health & Human Services | NIH | Fogarty International Center (FIC)
- D43 TW010937/TW/FIC NIH HHS/United States